Delivery Order SPE2DB20D1100-SPE2DB24FZ96F
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,490 units of insulin aspart 100 unit/mL pens. The $7,975.68 contract has a completion date of February 6, 2024 and was awarded on February 5, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation. The $12,058.56 contract is for the delivery of insulin aspart 100 unit/mL pens with a performance period ending on January 29, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $1,106.01 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Insulin Aspart 100 Unit/ML Pen 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,520.31 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of insulin glargine-yfgn U100 pens and has a completion date of February 12, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, provides a wide range of pharmaceutical products and medical supplies to U.S. government...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,822.60, is for the delivery of Insulin Aspart 100 Unit/ML Vials 10ML to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563589980 units of insulin aspart 100 unit/mL pens. The $10,290.77 order has a completion date of February 8, 2024 and was awarded on February 7, 2024. Amerisourcebergen Drug Corp, which does business as Cencora, Inc., is the prime contractor on this delivery order and has held an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, the prime contractor, for the supply of insulin aspart 100 unit/mL pens. This $5,984.94 award has a completion date of February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of Defense, through various indefinite delivery contracts with DLA. No set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,495.97, is for the delivery of insulin aspart 100 unit/ml pens with a completion date of January 29, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Pen, 3mL to the Defense Logistics Agency (DLA). The $1,829.60 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. The contract has a completion date of January 30, 2024. Amerisourcebergen Drug Corp also holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,088.30 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 unit/mL pens. This order is a part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FZ96FDelivery Order
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $2,195.52, is for the provision of Insulin Aspart 100 unit/mL pens with a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/30/24 |